Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

476
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
476
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

529
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
529
Altered States of Awareness01:06

Altered States of Awareness

870
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
870
Magical Thinking01:29

Magical Thinking

137
Magical thinking encompasses the belief in assumptions that defy logical reasoning yet appear intuitively convincing. It is a common psychological phenomenon that persists across various cultural and individual contexts. While these assumptions contradict empirical evidence and scientific laws, they often serve meaningful psychological roles in promoting emotional resilience and a sense of control, especially under stress or uncertainty.Thought-Action Fusion and the Law of SimilarityA key...
137
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

328
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
328
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

401
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
401

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up.

Alcohol and alcoholism (Oxford, Oxfordshire)·2025
Same author

Impact of psychedelics on craving in addiction: A systematic review.

Journal of psychopharmacology (Oxford, England)·2025
Same author

Reply to: 5-MeO-DMT has not been found in traditional ayahuasca preparations and the combination of 5-MeO-DMT with MAOIs is dangerous.

Human psychopharmacology·2022
Same author

N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.

Human psychopharmacology·2022
Same author

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.

Journal of psychoactive drugs·2022
Same author

Debunking the myth of 'Blue Mondays': No evidence of affect drop after taking clinical MDMA.

Journal of psychopharmacology (Oxford, England)·2021

Related Experiment Video

Updated: Dec 17, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.5K

Psilocybin occasioned mystical-type experiences.

Edward James1, Thomas L Robertshaw1, Mathew Hoskins2,3

  • 1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.

Human Psychopharmacology
|June 24, 2020
PubMed
Summary

Psilocybin-assisted therapy shows promise for psychiatric conditions, with mystical experiences linked to benefits. Further research is needed to understand mechanisms and clinical applications.

Keywords:
Psilocybinclinical applicationscurrent researchmystical-type experiencespsychotherapyquantum change

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.3K
Modulation of the Neurophysiological Response to Fearful and Stressful Stimuli Through Repetitive Religious Chanting
11:12

Modulation of the Neurophysiological Response to Fearful and Stressful Stimuli Through Repetitive Religious Chanting

Published on: November 4, 2021

3.8K

Related Experiment Videos

Last Updated: Dec 17, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

7.5K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.3K
Modulation of the Neurophysiological Response to Fearful and Stressful Stimuli Through Repetitive Religious Chanting
11:12

Modulation of the Neurophysiological Response to Fearful and Stressful Stimuli Through Repetitive Religious Chanting

Published on: November 4, 2021

3.8K

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Psychedelic therapy models, particularly using psilocybin, demonstrate potential for treating psychiatric disorders.
  • Mystical-type experiences induced by psilocybin correlate with significant therapeutic advantages and sustained improvements in mental well-being.

Purpose of the Study:

  • To review current research on psilocybin-induced mystical experiences and their therapeutic applications.
  • To evaluate the strengths and limitations of existing studies.
  • To explore novel perspectives and future research directions.

Main Methods:

  • This study employed a narrative review methodology.
  • It involved summarizing and assessing existing research on psilocybin, mystical experiences, and psychiatric treatment.
  • Contemporary methods for quantifying subjective effects were discussed.

Main Results:

  • Advancements since 2006 have enhanced understanding of psilocybin's therapeutic potential.
  • Pharmacological actions are increasingly understood, but neurological underpinnings of mystical experiences require further elucidation.
  • Potential applications extend to positive psychology interventions for healthy individuals.

Conclusions:

  • Significant progress has been made in psilocybin-assisted psychotherapy, yet neuromechanistic and clinical applicability require more investigation.
  • Challenges including funding, legal issues, and socio-cultural resistance impede further research.
  • Despite obstacles, the experimental evidence for psilocybin's therapeutic benefits is promising.